Autoimmune Diseases  >>  LX 2931  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
LX 2931 / Lexicon Pharma
NCT00903383: Study of LX3305 in Subjects With Active Rheumatoid Arthritis on Stable Methotrexate

Checkmark Data (RA)
Jun 2012 - Jun 2012: Data (RA)
Checkmark Data
Nov 2011 - Nov 2011: Data
Checkmark Data
More
Completed
2
208
US, Europe, RoW
LX3305 low dose, LX3305 mid dose, LX3305 high dose, Placebo
Lexicon Pharmaceuticals
Rheumatoid Arthritis
09/10
 

Download Options